(0)
Funded by the Bill & Melinda Gates Foundation and Global Grand Challenges Canada s Saving Lives at Birth initiative, the two research and validation studies include the integration of Biospectal OptiBP and focus on the routine measurement of blood pressure as well as assessment of hypertension during pregnancy
SAN FRANCISCO and LAUSANNE, Switzerland, May 20, 2021 /PRNewswire/
Biospectal, the remote patient monitoring and biosensing software company, today announced the next step in its commitment to global health by launching two independent research and validation studies using Biospectal OptiBP. Currently underway in four low-resource countries, the studies center on the routine measurement and monitoring of blood pressure, assessment of hypertension during pregnancy, and enable global field testing and validation of Biospectal s OptiBP smartphone app and data platform integration with the
Biospectal kündigt zwei unabhängige globale Gesundheitsforschungs- und Validierungsstudien mit der Biospectal OptiBP ™ Blutdruckmess-App an
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Biospectal annonce deux études indépendantes de recherche et de validation en santé mondiale à l aide de l application de mesure de la pression artérielle Biospectal OptiBP™
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Biospectal Announces Two Independent Global Health Research and Validation Studies Using Biospectal OptiBP™ Blood Pressure Measurement App
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.